7501 - 7510 of 7939 Results
Title
Year
-
OPENTitle: Neuroprotective activities of regulatory T cellsJournal Name: Trends in Molecular MedicinePublisher: Elsevier BVVol: 17Issue #: 12Start Page: 687End Page: 688Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.molmed.2011.08.005Best OA location URL: https://europepmc.org/articles/pmc5892451?pdf=renderCitation Count: 48
-
OPENTitle: Synthesis and SAR of a novel metabotropic glutamate receptor 4 (mGlu4) antagonist: Unexpected ‘molecular switch’ from a closely related mGlu4 positive allosteric modulatorJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 21Issue #: 23Start Page: 6955End Page: 6959Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2011.09.131Best OA location URL: https://europepmc.org/articles/pmc3319082?pdf=renderCitation Count: 16
-
OPENTitle: Relationship Between CSF Biomarkers of Alzheimer's Disease and Rates of Regional Cortical Thinning in ADNI DataJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 26Issue #: s3Start Page: 77End Page: 90Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-2011-0006Best OA location URL: https://europepmc.org/articles/pmc4587763?pdf=renderCitation Count: 47
-
OPENTitle: Discovery, Synthesis, and Structure–Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4) with Oral Efficacy in an Antiparkinsonian Animal ModelJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 54Issue #: 21Start Page: 7639End Page: 7647Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm200956qBest OA location URL: https://europepmc.org/articles/pmc3226828?pdf=renderCitation Count: 58
-
RESTRICTEDTitle: α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's DiseaseJournal Name: Pharmacological ReviewsPublisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)Vol: 63Issue #: 4Start Page: 938End Page: 966Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1124/pr.110.003269Best OA location URL: https://europepmc.org/articles/pmc3186078?pdf=renderCitation Count: 171
-
RESTRICTEDTitle: Cell Therapeutics in Parkinson's DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 8Issue #: 4Start Page: 539End Page: 548Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1007/s13311-011-0069-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-011-0069-6.pdfCitation Count: 78
-
OPENTitle: Plasticity in Early Alzheimer DiseaseJournal Name: Topics in Geriatric RehabilitationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 27Issue #: 4Start Page: 257End Page: 267Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/tgr.0b013e31821e588eBest OA location URL: https://europepmc.org/articles/pmc3419487?pdf=renderCitation Count: 36
-
RESTRICTEDTitle: Regulation of myocyte enhancer factor-2 transcription factors by neurotoxinsJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 32Issue #: 5Start Page: 563End Page: 566Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2011.05.019Best OA location URL: https://europepmc.org/articles/pmc3200477?pdf=renderCitation Count: 15
-
RESTRICTEDTitle: Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disordersJournal Name: Biochemical PharmacologyPublisher: Elsevier BVVol: 82Issue #: 8Start Page: 873End Page: 882Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bcp.2011.06.001Best OA location URL: https://europepmc.org/articles/pmc3264546?pdf=renderCitation Count: 78
-
OPENTitle: β-Hexachlorocyclohexane levels in serum and risk of Parkinson's diseaseJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 32Issue #: 5Start Page: 640End Page: 645Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2011.04.002Best OA location URL: https://doi.org/10.1016/j.neuro.2011.04.002Citation Count: 53